ICP Parking Lot/Vaccines: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{TOCright}}
{{TOCright}}
=[[Vaccines/Bibliography|Bibliography]]=
=Talks=
* [[Vaccines/Sara Crager on Vaccines]]
=Vaccines/Bibliography|Bibliography=
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf  
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf  
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf

Latest revision as of 20:12, 5 May 2010

Talks

Vaccines/Bibliography|Bibliography

  • 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
  • Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
  • Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
  • LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
  • Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med.
  • University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med.
  • The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med.
  • New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med.
  • Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med.
  • Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med.
  • Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med.
  • Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med.
  • Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med.
  • Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott

Navigation

Back to ICP Parking Lot
Back to Biotechnology_-_Genomic_and_Proteomics
Back to Main Page